Skip to content
Screener

Organogenesis Holdings Inc. ORGO Q1 2026 earnings

Reported May 7, 2026 · After market close

Revenue$36.3MMiss by $7.0M
EPS-$0.37Miss by $0.08
Revenue estimate$43.3M
EPS estimate-$0.29

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$52.1M
EPS estimate-$0.18

Financials

Q1 2026

Income statement

See full
Revenue$37.2M-57.1%
Operating income-$68.9M-158%
Net income-$53.2M-182%
EPS (diluted)-$0.44-159%

Balance sheet

See full
Cash & equivalents$91.4M-16.9%
Total debt$39.4M+24.8%
Total equity$244.6M+0.7%
Total assets$520.0M+11.3%

Cash flow

See full
Operating cash flow$21.1M+206%
CapEx$3.1M-13.2%
Free cash flow$18.0M+176%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$304.88M-44.4%
Enterprise value$252.92M-46.1%
P/E112.1×—
P/S0.6×-0.6×

Profitability

See full
Operating margin0.5%—
Net margin0.5%+0.3pp

Returns & leverage

See full
Return on equity1.1%+0.6pp
Debt / equity0.2×0.0×
Current ratio3.5×-0.6×

Segments

By product

See full
Grant$978.0K—

FAQ

When did Organogenesis Holdings Inc. report Q1 2026 earnings?
Organogenesis Holdings Inc. (ORGO) reported Q1 2026 earnings on May 7, 2026 after market close.
What were Organogenesis Holdings Inc.'s Q1 2026 revenue and EPS?
Organogenesis Holdings Inc. reported revenue of $36.3M and eps of $-0.37 for Q1 2026.
Did Organogenesis Holdings Inc. beat estimates in Q1 2026?
Revenue missed the consensus estimate of $43.3M by $7.0M. EPS missed the consensus estimate of $-0.29 by $0.08.
How did Organogenesis Holdings Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 58.2% from $86.7M a year earlier and eps declined 184.6% from $-0.13.
Where can I find Organogenesis Holdings Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001661181-26-000007) and the 10-Q periodic report (0001661181-26-000008) directly on SEC EDGAR. The filing index links above go to sec.gov.